免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

臨床試験

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

NCT: NCT06075901 · ENROLLING_BY_INVITATION

NCT識別子NCT06075901
ステータスENROLLING_BY_INVITATION
開始日2025-08-01
SponsorPaulista University (OTHER)
First posted
Last updated

概要

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。

↑